Difference between revisions of "Eli Lilly and Company"
m (→Affiliations) |
(→People) |
||
| Line 4: | Line 4: | ||
Eli Lilly and Company list their Board of Directors for 2007 as<ref> Elli Lilly and Company [http://investor.lilly.com/directors.cfm Director Profiles] Accessed 27th December 2007</ref>... | Eli Lilly and Company list their Board of Directors for 2007 as<ref> Elli Lilly and Company [http://investor.lilly.com/directors.cfm Director Profiles] Accessed 27th December 2007</ref>... | ||
| − | * [[Sidney Taurel]] - Chairman & CEO | + | * [[Sidney Taurel]] - Chairman & CEO. Taurel's biography<ref> Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4148&Group=2 Sidney Taurel] Accessed 31st January 2008</ref> describes how he first joined Eli Lilly in 1971 and took up his current positions of CEO in 1998 and Chairman in 1999. He is a member of the boards of [[IBM Corporation]], [[McGraw-Hill Companies Inc.]], the [[RCA Tennis Championships]], is a member of the board of overseers of the [[Columbia Business School]], a trustee at [[Indianapolis Museum of Art]], a member of The [[Business Council]] and The [[Business Roundtable]]. He is also on the [[Committee for Trade Policy and Negotiations]] and is an officer of the [[French Legion of Honor]]. Taurel was previously president and a member of the executive committee of the board of directors for the [[Pharmaceutical Research and Manufacturers of America]] (PhRMA) |
| − | * [[Winfried Bischoff]] | + | |
| − | * [[J. Michael Cook]] | + | * [[Winfried Bischoff]] - Bischoff's biography<ref>Eli Lilly and Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=4454&Group=2 Winifried Bischoff] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2000. Bischoff is also chairman of [[Citi Europe]], on the management committee of [[Citi Inc.]], a nonexecutive director of The [[McGraw-Hill Companies]] and [[Land Securities plc]], a member of the [[City Promotion Panel]] and a member of the [[Council for Industry and Higher Education]]. HIs previous involvements include serving [[J Henry Schroder & Co. Limited]], [[Schroders Asia Limited]] and [[Schroders plc]]. He has also previously served on the boards of [[Siemens Holdings plc]], [[Cable and Wireless plc]] and [[IFIL Finanziaria di Partecipazioni SPA]], Italy. |
| − | * [[Martin S Feldstein]] | + | |
| + | * [[J. Michael Cook]] - Cook's biography<ref>Eli Lilly Company [http://investor.lilly.com/corpgov-BioDetail.cfm?BioID=7346&Group=2 J Michael Cook] Accessed 31st January 2008</ref> reports that he joined Eli Lilly in 2005. Cook also serves as a member of the Advisory Council of the [[Public Company Accounting Oversight Board]], is a trustee of the [[Scripps Research Institute]], is on the boards of [[Comcast Corp.]], [[International Flavors & Fragrances Inc.]], [[AT&T Corp.]], [[Fidelity Group of Mutual Funds]], [[HCA]] – The Healthcare Co., [[Northrop Grumman Corp.]] and [[Rockwell International]]. He is chair of the audit committees for [[Comcast]] and [[International Flavors & Fragrances Inc.]]. He also serves as chairman of the [[Accountability Advisory Council to the Comptroller General of the United States]], is a member of the [[National Association of Corporate Directors Blue Ribbon Panel on Corporate Governance]] and was named the 62nd member of the [[Accounting Hall of Fame]] in 1999. Cooks previous involvements include serving as chairman and chief executive officer of [[Deloitte and Touche]] LLP and as past president of the [[Institute of Outstanding Directors]]. Cook is also reported to have 'written and spoken extensively on international accounting standards, business globalization, auditor independence, corporate governance, gender equality in the workplace, tort and securities law reform, and he has often testified before Congress on professional issues'. | ||
| + | * [[Martin S Feldstein]] - | ||
* [[George M C Fisher]] | * [[George M C Fisher]] | ||
* [[J Erik Fyrwald]] | * [[J Erik Fyrwald]] | ||
Revision as of 11:40, 31 January 2008
Contents
People
Board of Directors
Eli Lilly and Company list their Board of Directors for 2007 as[1]...
- Sidney Taurel - Chairman & CEO. Taurel's biography[2] describes how he first joined Eli Lilly in 1971 and took up his current positions of CEO in 1998 and Chairman in 1999. He is a member of the boards of IBM Corporation, McGraw-Hill Companies Inc., the RCA Tennis Championships, is a member of the board of overseers of the Columbia Business School, a trustee at Indianapolis Museum of Art, a member of The Business Council and The Business Roundtable. He is also on the Committee for Trade Policy and Negotiations and is an officer of the French Legion of Honor. Taurel was previously president and a member of the executive committee of the board of directors for the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Winfried Bischoff - Bischoff's biography[3] reports that he joined Eli Lilly in 2000. Bischoff is also chairman of Citi Europe, on the management committee of Citi Inc., a nonexecutive director of The McGraw-Hill Companies and Land Securities plc, a member of the City Promotion Panel and a member of the Council for Industry and Higher Education. HIs previous involvements include serving J Henry Schroder & Co. Limited, Schroders Asia Limited and Schroders plc. He has also previously served on the boards of Siemens Holdings plc, Cable and Wireless plc and IFIL Finanziaria di Partecipazioni SPA, Italy.
- J. Michael Cook - Cook's biography[4] reports that he joined Eli Lilly in 2005. Cook also serves as a member of the Advisory Council of the Public Company Accounting Oversight Board, is a trustee of the Scripps Research Institute, is on the boards of Comcast Corp., International Flavors & Fragrances Inc., AT&T Corp., Fidelity Group of Mutual Funds, HCA – The Healthcare Co., Northrop Grumman Corp. and Rockwell International. He is chair of the audit committees for Comcast and International Flavors & Fragrances Inc.. He also serves as chairman of the Accountability Advisory Council to the Comptroller General of the United States, is a member of the National Association of Corporate Directors Blue Ribbon Panel on Corporate Governance and was named the 62nd member of the Accounting Hall of Fame in 1999. Cooks previous involvements include serving as chairman and chief executive officer of Deloitte and Touche LLP and as past president of the Institute of Outstanding Directors. Cook is also reported to have 'written and spoken extensively on international accounting standards, business globalization, auditor independence, corporate governance, gender equality in the workplace, tort and securities law reform, and he has often testified before Congress on professional issues'.
- Martin S Feldstein -
- George M C Fisher
- J Erik Fyrwald
- Alfred G Gilman
- Karen N Horn
- John C Lechleiter
- Ellen R Marram
- Franklyn G Prendergast
- Kathi P Seifert
Executive Management
Eli Lilly and Company list their Executive Management for 2007 as comprising[5]...
- Sidney Taurel - Chairman and Chief Executive Officer
- Robert A Armitage - Senior Vice President and General Counsel
- Robert W Armstrong - Vice President, Global External Research and Development, Lilly Research Laboratories
- Alex M Azar II - Senior Vice President, Corporate Affairs and Communications
- Alan Breier - Vice President for Medical and Chief Medical Officer
- Bryce D Carmine - President, Global Product Development
- William W Chin - Vice President, Discovery Research and Clinical Investigation
- Robert A Cole - Vice President, Global Engineering and Environmental Health and Safety
- Deirdre P Connelly - President, Lilly USA
- Newton F Crenshaw - President and General Manager, Lilly Japan
- Andrew M Dahlem - Vice President, Lilly Research Labs Operations
- Frank M Deane - President, Manufacturing
- Alecia A DeCoudreaux - Vice President and General Counsel
- Johanna Carmel Egan - Vice President, Project Management
- Timothy R. Franson - Vice President, Global Regulatory Affairs
- Thomas W Grein - Vice President and Treasurer
- Simon N R Harford - Vice President and Controller
- Michael C Heim - Vice President, Information Technology and Chief Information Officer
- Abbas Hussain- Vice President Europe
- Patrick C James - President, Elanco Animal Health
- Peter J Johnson - Executive Director, Corporate Strategic Planning
- Elizabeth H Klimes - Vice President, Six Sigma
- John C Lechleiter - President and Chief Operating Officer
- Patricia Martin - Vice President, Global Diversity
- Anthony Murphy - Senior Vice President, Human Resources
- Anne Nobles - Vice President, Compliance and Enterprise Risk Management and Chief Compliance Officer
- Steven M Paul - Executive Vice President, Science and Technology, President of Lilly Research Laboratories
- Richard D Pilnik - Group Vice President and Chief Marketing Officer
- Derica W Rice - Senior Vice President and Chief Financial Officer
- Gino Santini - Senior Vice President, Corporate Strategy and Policy
- Sharon L Sullivan - Vice President, Human Resources–Global Compensation and HR Services
- Lorenzo Tallarigo - President, International Operations
- Jacques Tapiero - President, Intercontinental Operations
- Albertus van den Bergh - Vice President, Global Customer Solutions
- Thomas Verhoeven - Vice President for Process and Product Development
- Fionnuala Walsh - Vice President of Quality
- James A Ward - Vice President and Chief Procurement Officer
Patient Groups
Eli Lilly and Company UK report their relationships with Patient Groups in 2006 as follows[6]...
- British Lung Foundation - £20,000, all of which is dedicated to the UK Lung Cancer Coalition.
- Cancer Research UK Scotland - £1,500
- Cancerbackup - £23,000
- Continence Foundation - £11,800 (Lilly in partnership with Boehringer Ingelheim)
- Depression Alliance - $15,000 (Lilly in partnership with Boehringer Ingelheim)
- Diabetes UK - £31,836
- Diabetes UK Scotland - £500
- Hafal - £5,000
- MDF The BiPolar Organisation - £5,000
- Men’s Health Forum - £7,500
- Men’s Health Forum Scotland - £500
- Mesothelioma UK (National Macmillan Mesothelioma Resource Centre) - £20,000
- National Schizophrenia Fellowship (Scotland) - £5,000
- Rethink - £25,000
- Roy Castle Lung Cancer Foundation - £2,000
- Royal National Institute of the Blind Scotland - £4,000
- Sexual Dysfunction Association - £25,000
In 2006, the Lilly Grants Committee has made the following grants:
- Amersham and High Wycombe Branch of the Parkinson´s Disease Society - £400
- Birmingham Parents Group - £200
- British Lung Foundation Scotland - £900
- Centre for Mental Health - £15,000 (in partnership with Boehringer Ingelheim)
- Children´s Holiday Foundation Devon - £250
- Clydebank Asbestos Group - £17,560
- Diabetes Calshot Holiday - £100
- Diabetes West Midlands - £200
- Macmillan Cancer Relief - £2,000
- Mencap - £100
- National Osteoporosis Society (Winchester Support Group) - £100
- National Osteoporosis Society - £250
- Perth and Kinross ADHD Support Group - £1,412
- SeeAbility - £100
- TB Alert - £1,500
- The Tern Veterinary Group - £100
- Winchester Deanery Children´s Society - £150
Affiliations
Eli Lilly list some of their alliances with other organisations as follows[7]. The exact nature and timescales of the alliances are not disclosed.
- Alkermes Inc. - Research & Development alliance to develop inhaled formulations of insulin
- Nicholas Piramal India Limited - Research & Development alliance in the development of several pre-clinical drug candidates
- Structural GenomiX Inc. - Research & Development alliance.
- Amylin Pharmaceuticals Inc. - Commercialization alliance, development and commercialization of diabetes therapies.
- Quintiles Transnational Corp. - Commercialization alliance, promotion & marketing
- Boehringer Ingelheim - Commercialization alliance, promotion & marketing
- Lonza Group - Manufacturing alliance
Particia Martin, Executive Director of alliance management at Eli Lilly reported to Pharmaceutical Executive [8] that Lilly has been partnering for a long time and is involved in hundreds of alliances.
Eli Lilly provided generous support for the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[9]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca). Michael Hogan and Laurie Flynn were also involved in this initiative.
References
- ↑ Elli Lilly and Company Director Profiles Accessed 27th December 2007
- ↑ Eli Lilly and Company Sidney Taurel Accessed 31st January 2008
- ↑ Eli Lilly and Company Winifried Bischoff Accessed 31st January 2008
- ↑ Eli Lilly Company J Michael Cook Accessed 31st January 2008
- ↑ Eli Lilly and Company Executive Management Accessed 27th December 2007
- ↑ Eli Lilly and Company Patient Group Relationships Accessed 31st December 2007
- ↑ Eli Lilly and Company Alliances Accessed 31st December 2007
- ↑ Pharmaceutical Executive Biotech and Pharma - Why Alliances FailAccessed 31st December 2007
- ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
